Tuesday, October 20, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Medicine

Single-center Bogotá study finds 24.9% STI prevalence among PrEP users

October 20, 2026
in Medicine
Ophelia Keating
By Ophelia Keating Scienmag Editorial Profile - Health Services Research
Reading Time: 3 mins read
0
Single-center Bogotá study finds 24.9% STI prevalence among PrEP users

Single-center Bogotá study finds 24.9% STI prevalence among PrEP users

65
SHARES
587
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

A cross-sectional study of 185 people enrolled in a HIV pre-exposure prophylaxis, or PrEP, program at a single center in Bogotá, Colombia, found that 24.9% were infected with at least one of three genital sexually transmitted infection-associated microorganisms. The result, reported in BMC Infectious Diseases , had a 95% confidence interval of 20.64% to 29.08%. Most infections were asymptomatic, indicating that the absence of reported symptoms did not exclude infection within this population.

The study evaluated participants between July and September 2024, with most—84.8%—using a daily PrEP regimen. Among the 46 participants identified as cases, Ureaplasma urealyticum was the most frequently detected microorganism, accounting for 35 infections, or 76.1% of cases. Chlamydia trachomatis and Neisseria gonorrhoeae each accounted for 19.5% of cases.

These organism-specific percentages describe the distribution of detected infections among the 46 cases, whereas the 24.9% estimate applies to prevalence across all 185 enrolled patients. The researchers conducted univariate and multivariate analyses to identify variables associated with higher infection prevalence and calculated prevalence ratios with 95% confidence intervals. Two reported sexual practices were independently associated with a higher prevalence of infection.

Group sex had a multivariate prevalence ratio of 6.33, with a 95% confidence interval of 2.37 to 18.2 and a p value below 0.001. Fisting was also independently associated with infection, with a prevalence ratio of 2.18, a 95% confidence interval of 1.37 to 3.49 and a p value below 0.001. The confidence intervals for the group-sex estimate were especially broad, indicating substantial uncertainty in the magnitude of that association, although its direction was positive in the reported model.

Clinical management differed by the microorganism detected, according to the study. Participants with N. gonorrhoeae and C. trachomatis received treatment, while cases of U. urealyticum were treated only when symptoms were present. Because asymptomatic infections were the most common presentation in the cohort, symptom-based detection alone would have missed much of the observed prevalence.

The study’s central finding was that the population using PrEP had a substantial burden of infection with all three microorganisms tested, with group sex and fisting independently associated with higher prevalence. The findings should be interpreted as a snapshot from one center rather than a measure of incidence, long-term trends or prevalence across all PrEP users. It therefore cannot establish whether PrEP use itself influenced infection prevalence or whether the observed patterns differ from those in other populations.

The sample size, single-center setting and three-month recruitment period also limit how broadly the results can be generalized. The authors’ conclusion was that regular STI screening and tailored prevention strategies are important in this population, making the study’s high prevalence and frequent asymptomatic infection central concerns for services already reaching people through PrEP programs.

Subject of Research: Cross-sectional assessment of genital STI prevalence and associated factors among 185 PrEP users at one Bogotá center

Article Title: Prevalence and factors associated with genital Chlamydia trachomatis, Neisseria gonorrhoeae and Ureaplasma urealyticum infections among patients in a preexposure prophylaxis (PrEP) program at a single center in Bogotá, Colombia

Article References: Florez, Y. F. M., Bolivar, Z. R., Brochero, C. R. D., Rubio, A. P. G., Rojas, L. T., Coronado, S. O., Dallos, V. V., Guerra, S. A., Diaz, J. S. M., & Beltran, S. L. V. (2026). Prevalence and factors associated with genital Chlamydia trachomatis, Neisseria gonorrhoeae and Ureaplasma urealyticum infections among patients in a preexposure prophylaxis (PrEP) program at a single center in Bogotá, Colombia. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-13404-5

Image Credits: AI Generated

DOI: 10.1186/s12879-026-13404-5

Keywords: PrEP, sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, Ureaplasma urealyticum, Bogotá, asymptomatic infection, prevalence, group sex, fisting, factors, associated

Cite Scienmag News

Ophelia Keating. (October 20, 2026). Single-center Bogotá study finds 24.9% STI prevalence among PrEP users. Scienmag. https://scienmag.com/single-center-bogota-study-finds-24-9-sti-prevalence-among-prep-users/

Ophelia Keating. "Single-center Bogotá study finds 24.9% STI prevalence among PrEP users." Scienmag, 20 October 2026, https://scienmag.com/single-center-bogota-study-finds-24-9-sti-prevalence-among-prep-users/. Accessed 20 October 2026.

Ophelia Keating. "Single-center Bogotá study finds 24.9% STI prevalence among PrEP users." Scienmag. October 20, 2026. https://scienmag.com/single-center-bogota-study-finds-24-9-sti-prevalence-among-prep-users/

Tags: associatedasymptomatic infectionasymptomatic STI infectionsBogotáChlamydia trachomatisChlamydia trachomatis and Neisseria gonorrhoeae among PrEP userscross-sectional study on STI among PrEP patientsfactorsfistinggroup seximpact of sexual practices on STI prevalenceimportance of routine STI screening forNeisseria gonorrhoeaePrEPprevalencePrevalence of sexually transmitted infections among PrEP users in Bogotárisk factors for STI in PrEP populationssexually transmitted infectionsSTI prevalence in Colombian PrEP clinicsSTI screening in PrEP programsUreaplasma urealyticumUreaplasma urealyticum in STI prevalence
Share26Tweet16
Previous Post

Working-memory signal changes sides as remembered objects cross the midline

Next Post

Rat study finds exercise-dependent BDNF and cognitive responses

Related Posts

Rat study finds exercise-dependent BDNF and cognitive responses
Medicine

Rat study finds exercise-dependent BDNF and cognitive responses

October 20, 2026
Legal Anonymity Raised Personal Injury Settlements by 12–17%
Medicine

Legal Anonymity Raised Personal Injury Settlements by 12–17%

October 20, 2026
Blood pressure and heart risk emerge as multiple myeloma clues
Medicine

Blood pressure and heart risk emerge as multiple myeloma clues

October 20, 2026
Dementia Care Showed Selective Analgesic Shifts After CDC Opioid Guideline
Medicine

Dementia Care Showed Selective Analgesic Shifts After CDC Opioid Guideline

October 20, 2026
Blood inflammation-albumin ratio linked to early decline after ischemic stroke
Medicine

Blood inflammation-albumin ratio linked to early decline after ischemic stroke

October 20, 2026
Ivermectin blunts cisplatin effects in oral cancer cells
Medicine

Ivermectin blunts cisplatin effects in oral cancer cells

October 20, 2026
Next Post
Rat study finds exercise-dependent BDNF and cognitive responses

Rat study finds exercise-dependent BDNF and cognitive responses

  • Mothers who receive childcare support from maternal grandparents show more optimized

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27656 shares
    Share 11059 Tweet 6912
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1061 shares
    Share 424 Tweet 265
  • Bee body mass, pathogens and local climate influence heat tolerance

    682 shares
    Share 273 Tweet 171
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    546 shares
    Share 218 Tweet 137
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    531 shares
    Share 212 Tweet 133
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Wheat remembers the cold: Molecular changes prepare plants for the next chill
  • Rat study finds exercise-dependent BDNF and cognitive responses
  • Single-center Bogotá study finds 24.9% STI prevalence among PrEP users
  • Working-memory signal changes sides as remembered objects cross the midline

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Science News
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,150 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading